MAPT and Mental deterioration: The novel N-terminal tau fragment (NT1) in plasma is not only a biomarker to distinguish normal, MCI, and AD dementia populations with high specificity and sensitivity, but is also a strong predictor of future cognitive decline and neurodegeneration in healthy elderly individuals (131, 132).